Core Insights - SOHM, Inc. is a pharmaceutical and biotechnology company focused on generic drugs and gene-editing tools, recognized as a leader in Gene Editing and Cell Engineering [1] - Recent FDA commentary and industry analyses indicate an evolution in regulatory pathways for genome-editing technologies, emphasizing the growing regulatory focus on precision-engineered genetic tools [1] - The developments also highlight advancements in non-viral delivery approaches and scalable manufacturing frameworks within the industry [1]